Molecular Docking of Brazilin from Secang Wood Plant (Caesalpinia sappan L.) as an Anti-Breast Cancer

Authors

  • Dewi Astriany Sekolah Tinggi Farmasi Indonesia, Indonesia https://orcid.org/0000-0001-5566-4240
  • Umi Baroroh Sekolah Tinggi Farmasi Indonesia, Indonesia
  • Khotibul Umam Sekolah Tinggi Farmasi Indonesia, Indonesia

DOI:

https://doi.org/10.15575/ak.v11i1.35590

Keywords:

brazilin, secang, molecular docking, receptor, breast cancer

Abstract

Breast cancer is a disease characterized by abnormal cell growth, which can invade adjacent tissues or metastasize to other organs. Secang (Caesalpinia sappan L.) is a plant that has been used as an alternative medicine for a variety of health conditions, including some types of cancer. This study aims to determine whether the brazilin compound found in secang wood can interact with the target receptors estrogen alpha, 17-β-HSD-1, and NUDT5, potentially serving as an anticancer candidate. Molecular docking simulations were employed to identify the molecular interactions of brazilin against estrogen receptor alpha (ERα) (PDB ID: 3ERT), 17β-HSD-1 (PDB ID: 3HB5), and NUDT5 (PDB ID: 5NQR) using AutoDockTools software. The results showed that the best free-binding energy (ΔG) value obtained for brazilin against the 17-β-HSD-1 receptor was -9.16 kcal/mol, with an inhibition constant of 192.45 nM. The ΔG value of brazilin with estrogen alpha was -6.68 kcal/mol, and the ΔG value for brazilin against NUDT5 was -4.8 kcal/mol. Brazilin has a higher potency compared to innate ligands based on the docking result of estrogen alpha receptor and NUDT5. Some structural similarities and interactions occurred between the amino acids GLY186 and TYR155 in brazilin with the binding of amino acids formed in the innate ligand against the 17-β-HSD-1 receptor, thus showing similar affinity to the 17-β-HSD1 receptor. In silico approaches provided valuable insights into the potential of brazilin as an anti-breast cancer agent.

References

S. Suyatmi, A. Mudigdo, B. Purwanto, D. Indarto, F. A. Hakim, and D. I. Krisnawati, “Brazilin isolated from Caesalpina sappan wood induces intrinsic apoptosis on A549 cancer cell line by increasing p53, caspase-9, and caspase-3,†Asian Pacific Journal of Cancer Prevention, 23 (4), 1337–1343, 2022, https://doi.org/10.31557/APJCP.2022.23.4.1337

Ministry of Health Republic of Indonesia, Indonesian Health Profile 2020. Jakarta, 2021.

I. P. W. Nugraha, I. W. Suwartawan, P. A. A. Prayoga, N. P. L. Laksmiani, I. G. P. Putra, and N. K. S. Ani, “Potensi brazilein dari kayu secang (Caesalpinia sappan L.) sebagai agen depigmentasi kulit secara In Silico,†Jurnal Farmasi Udayana, 7(1), 2018, https://doi.org/10.24843/JFU.2018.v07.i01.p02

R. Rachmady, L. Muntafiah, F. Rosyadi, I. Sholihah, S. Handayani, and R. I. Jenie, “Antiproliferative effect of secang heartwood ethanolic extract (Caesalpinia sappan L.) on HER2-Positive breast cancer cells,†Indonesian Journal of Cancer Chemoprevention, 7(1), 1–5, 2017, https://doi.org/10.14499/indonesianjcanchemoprev7iss1pp1-5

C. N. Raptania, S. Zakia, A. I. Fahira, and R. Amalia, “Article review: Brazilin as potential anticancer agent,†Frontiers in Pharmacology, 15 (1355533). Frontiers Media SA, pp. 1–9, 2024. https://doi.org/10.3389/fphar.2024.1355533

T. Vij et al., “A comprehensive review on bioactive compounds found in Caesalpinia sappan,†Molecules, 28 (17), 1–22, 2023, https://doi.org/10.3390/molecules28176247

R. Sari and Suhartati, “Secang (Caesalpinia sappan L.) : tumbuhan herbal kaya antioksidan,†Info Teknis EBONI, 13 (1), pp. 57–67, 2016. doi:10.20886/buleboni.5077

M. Mazumdar, D. Fournier, D. W. Zhu, C. Cadot, D. Poirier, and S. X. Lin, “Binary and ternary crystal structure analyses of a novel inhibitor with 17β-HSD type 1: A lead compound for breast cancer therapy,†Biochemical Journal, 424 (3), 357–366, Dec. 2009, https://doi.org/10.1042/BJ20091020

C. I. Gonçalves, J. Carriço, M. Bastos, and M. C. Lemos, “Disorder of sex development due to 17-Beta-Hydroxysteroid dehydrogenase type 3 deficiency: A Case Report and Review of 70 Different HSD17B3 Mutations Reported in 239 Patients,†Int J Mol Sci, 23 (17), 2022, https://doi.org/10.3390/ijms231710026

F. Li et al., “SiRNA-based breast cancer therapy by suppressing 17β-hydroxysteroid dehydrogenase type 1 in an optimized xenograft cell and molecular biology model in vivo,†Drug Des Devel Ther, 13,757–766, 2019, https://doi.org/10.2147/DDDT.S180836

A. P. D. Harnis, N. A. H. M. Hasan, Y. K. Janah, C. A. Tsamara, and F. Fatchiyah, “Virtual inhibition analysis of bioactive compound Brazilin (Caesalpinia sappan L.) toward progesterone receptor or lonaprisan in breast cancer proliferation,†Biotropika: Journal of Tropical Biology, 8 (2), 62–70, 2020, https://doi.org/10.21776/ub.biotropika.2020.008.02.01

B. D. G. Page et al., “Targeted NUDT5 inhibitors block hormone signaling in breast cancer cells,†Nat Commun, 9 (250), 1–14, 2018, https://doi.org/10.1038/s41467-017-02293-7

N. D. Amalina, M. Suzery, B. Cahyono, and D. N. Bima, “Mengungkap potensi metabolit sekunder tanaman herbal Indonesia untuk menghentikan metastasis kanker payudara: Pendekatan in-silico,†Indonesian Journal of Chemical Science , 9 (3), 154–159, 2020, [Online]. Available:http://journal.unnes.ac.id/sju/index.php/ijcs

S. Nur, M. Hanafi, H. Setiawan, N. Nursamsiar, and B. Elya, “Molecular docking simulation of reported phytochemical compounds from Curculigo latifolia extract on target proteins related to skin antiaging,†Tropical Journal of Natural Product Research, 7 (11), 5067–5080,2023,https://doi.org/10.26538/tjnpr/v7i11.9

M. V. C. Grahl et al., “Evaluation of drug repositioning by molecular docking of pharmaceutical resources available in the Brazilian healthcare system against SARS-CoV-2,†Inform Med Unlocked, 23, 1–8, 2021, https://doi.org/10.1016/j.imu.2021.100539

C. Arjin et al., “Brazilin from Caesalpinia sappan inhibits viral infection against PRRSV via CD163ΔSRCR5 MARC-145 cells: an in silico and in vitro studies,†Sci Rep, 12 ( 21595), 1–15, 2022, https://doi.org/10.1038/s41598-022-26206-x

“BIOVIA discovery studio modeling environment,†2017, Dassault Systèmes, San Diego, CA. Accessed: Jul. 23, 2023. [Online]. Available: https://discover.3ds.com/discovery-studio-visualizer-download.

D. Dermawan, R. Sumirtanurdin, and D. Dewantisari, “Simulasi dinamika molekular reseptor Estrogen Alfa dengan Andrografolid sebagai anti kanker payudara,†Indonesian Journal of Pharmaceutical Science and Technology, 6(2), 65–76, 2019, https://doi.org/10.24198/ijpst.v6i2.18168

G. M. Morris et al., “Software news and updates AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility,†J Comput Chem, 30 (16), 2785–2791,2009,https://doi.org/10.1002/jcc.21256

M. Hahn, “Receptor surface models: definition and construction,†J. Med. Chem, 38, 2080–2090, 1995, https://doi.org/10.1021/jm00012a007

I. K. Klara, R. M. Purwono, and P. Achmadi, “Analisis in silico senyawa Flavonoid kayu secang (Caesalpinia sappan L.) pada reseptor α-Amilase sebagai Antihiperglikemik,†Acta Vet Indones, 11(3), 210–219, 2023, https://doi.org/10.29244/avi.11.3.210-219

L. Veterini et al., “In Silico study of the potential of garlic allicin compound as anti-angiogenesis in breast cancer,†Tropical Journal of Natural Product Research, 5 (11), 1995–1999, 2021, https://doi.org/10.26538/tjnpr/v5i11.17

M. N. Abdillah, N. R. Ilmah, and A. Bintang Mahardhika, “Penambatan molekuler senyawa Polifenolat terhadap enzim reverse transcriptase sebagai senyawa antiretroviral (HIV-1),†JSTFI Indonesian Journal of Pharmaceutical Science and Technology, 6(1), pp. 1-13,2017, https://doi.org/10.58327/jstfi.v6i1.59

Downloads

Published

2024-08-01

Issue

Vol. 11 No. 1 (2024): al Kimiya: Jurnal Ilmu Kimia dan Terapan

Section

Articles

Citation Check

License

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution 4.0 International License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).